Herbert Tilg

基本信息

Career Trajectory

Bio

Tilg ist bekannt für seine Arbeiten über chronische Entzündungsmechanismen und die Rolle von Entzündungsmediatoren (Zytokinen). Zuletzt fokussierte sich sein Interesse auf die Rolle der Darmbakterien bei metabolischer Entzündung und assoziierten Erkrankungen wie Fettlebererkrankung und Typ-2- Diabetes. Er konnte diesbezüglich auch international beachtete Krankheitshypothesen aufstellen.

Research Interests

Papers共 881 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: the Second ROME Consensus Conference

Inflammatory bowel diseases (2025)

Cited0Views0WOSBibtex

Integrated Summary of Safety of Obefazimod for Patients with Moderately to Severely Active Ulcerative Colitis

S. Vermeire,L. Peyrin-Biroulet,S. Danese,M. Dubinsky,P. S. Dulai,H. Tilg,B. Siegmund,T. Hisamatsu,K. Shan,D. Jacobstein,F. Cataldi,C. Rabbat,B. E. Sands

JOURNAL OF CROHNS & COLITIS (2025): i1554-i1555

Cited0Views0Bibtex

P0636 Impact of Obefazimod Treatment on Histologic and Combined Histologic and Endoscopic Outcomes in Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b Open-Label Maintenance Study

F. Magro,L. Peyrin-Biroulet,L. Biedermann,B. E. Sands,S. Danese,P. S. Dulai,M. Dubinsky,H. Tilg,B. Siegmund,T. Hisamatsu,K. Shan,D. Jacobstein,F. Cataldi,C. Rabbat,S. Vermeire

JOURNAL OF CROHNS & COLITIS (2025): i1251-i1252

Cited0Views0Bibtex

Efficacy and Safety of Obefazimod for the Fourth and Sixth Year of Open-Label Maintenance Treatment in Patients with Moderately to Severely Active Ulcerative Colitis (UC): 2-Year Interim Analysis after Dose De-Escalation to 25 Mg

S. Danese,B. E. Sands,P. S. Dulai,L. Peyrin-Biroulet,M. Dubinsky,H. Tilg,B. Siegmund,T. Hisamatsu,K. Shan, P. Ploncard,D. Jacobstein,F. Cataldi,C. Rabbat,S. Vermeire

JOURNAL OF CROHNS & COLITIS (2025): i1684-i1684

Cited0Views0Bibtex

The Common Genetic Variant Rs1278960 Determining Expression of Interferon-lambda Predicts Inflammatory Response in Critically Ill COVID-19 Patients

Timo Mayerhöfer,Michael Joannidis, Sebastian Klein,Andre Franke, Sara Margarita,Luisa Ronzoni,Elke Pertler,Sonja Wagner,Sabina Sahanic,Ivan Tancevski, David Haschka, Christoph Hochhold,Benedikt Treml,Luca Valenti,Herbert Tilg,Benedikt Schaefer,Heinz Zoller

Scientific reportsno. 1 (2025): 15802-15802

Cited0Views0WOSNATUREBibtex

P0889 Efficacy and Safety of Obefazimod for the Fourth and Sixth Year of Open-Label Maintenance Treatment in Patients with Moderately to Severely Active Ulcerative Colitis (UC): 2-Year Interim Analysis after Dose De-Escalation to 25 Mg

S Danese,B E Sands,P S Dulai,L Peyrin-Biroulet,M Dubinsky,H Tilg,B Siegmund,T Hisamatsu,K Shan, P Ploncard,D Jacobstein,F Cataldi,C Rabbat,S Vermeire

Journal of Crohn's and Colitisno. Supplement_1 (2025)

Cited0Views0Bibtex

DOP028 the Resolution of Fecal Calprotectin Configurations and Their Biological Functions in Gut Inflammation

A Jukic,R Hilbe, L Zundel,P Willeit, K Vouk,K Faserl,A Zollner, M Meyer, A Kozsar,J Schwärzler, V Marteau,A Vich Vila,F Grabherr,L Mayr,K Aden,R K Weersma,Z Trajanoski,H Tilg,T E Adolph

Journal of Crohn's and Colitisno. Supplement_1 (2025)

Cited0Views0Bibtex

Isotretinoin Treatment Protects Against Crohn's Disease Development and Suppresses Pro-Inflammatory Cytokines That Drive Experimental Enteritis

M. Meyer,F. Grabherr, M. Hadjihannas,J. Schwaerzler,L. Mayr,A. Jukic,B. Enrich, L. Scheffauer, L. Zundel,A. Zollner,C. Grander, A. Franke,H. Tilg,T. E. Adolph

JOURNAL OF CROHNS & COLITIS (2025): I533-I533

Cited0Views0Bibtex

The Microbiome for Clinicians

Serena Porcari, Siew C Ng,Laurence Zitvogel,Harry Sokol, Rinse K Weersma,Eran Elinav,Antonio Gasbarrini,Giovanni Cammarota,Herbert Tilg,Gianluca Ianiro

Cellno. 11 (2025): 2836-2844

Cited0Views0WOSBibtex

Risk of Serious Bacterial and Non-Bacterial Infections in People with MASLD

Giovanni Targher,Herbert Tilg,Luca Valenti

Liver international official journal of the International Association for the Study of the Liverno. 4 (2025): e70059-e70059

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Professor

Papers共 881 篇Author StatisticsCo-AuthorSimilar Experts